The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Courses
This course explores the role of leaders in developing effective teams that meet both functional and organizational goals in recruiting, developing…
Courses
This course outlines the role of leaders in building a culture of continual improvement and provides guidance on how to achieve it.
Courses
This course explores the fundamentals of leadership development and reveals what distinguishes good leaders from great ones.
Courses
The Foundations for Effective Leadership series is designed to cultivate, develop and grow effective leaders and to align strategic visions with…
This course provides an introduction to the AHRMM Cost, Quality, and Outcomes (CQO) Movement.